Search

Your search keyword '"Masse S"' showing total 402 results

Search Constraints

Start Over You searched for: Author "Masse S" Remove constraint Author: "Masse S"
402 results on '"Masse S"'

Search Results

201. Fusion of structural and functional cardiac magnetic resonance imaging data for studying ventricular fibrillation.

202. A novel approach to quantification of real and artifactual components of current density imaging for phantom and live heart.

203. The effects of long chain polyunsaturated fatty acids on local activation properties in dogs vulnerable to atrial fibrillation.

204. Introduction of disulfide bridges within silica nanoparticles to control their intra-cellular degradation.

205. Analysis of reliability metrics and quality enhancement measures in current density imaging.

206. Automated signal pattern detection in ECG during human ventricular arrhythmias.

207. Blind source separation in characterizing ECG pre-shock waveforms during Ventricular Fibrillation.

208. Controlled exposure study of air pollution and T-wave alternans in volunteers without cardiovascular disease.

209. Studying semblances of a true killer: experimental model of human ventricular fibrillation.

210. ILK induces cardiomyogenesis in the human heart.

211. Synthesis and Characterization of Nanoapatites Organofunctionalized with Aminotriphosphonate Agents.

212. Ultrasound-assisted synthesis of mesoporous zirconia-hydroxyapatite nanocomposites and their dual surface affinity for Cr3+/Cr2O7(2-) ions.

213. The effect of air pollution on spatial dispersion of myocardial repolarization in healthy human volunteers.

214. Wavelet-based features for characterizing ventricular arrhythmias in optimizing treatment options.

215. Relating spatial heterogeneities to rotor formation in studying human ventricular fibrillation.

216. Predicting refibrillation from pre-shock waveforms in optimizing cardiac resuscitation.

217. Role of carboxylate chelating agents on the chemical, structural and textural properties of hydroxyapatite.

218. Phase mapping of cardiac fibrillation.

219. Wavelet-based markers of ventricular fibrillation in optimizing human cardiac resuscitation.

220. Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A.

221. Influence of cyclic polyamines on silica formation during the Stöber process.

222. Short-term memory and restitution during ventricular fibrillation in human hearts: an in vivo study.

223. Regional frequency variation during human ventricular fibrillation.

224. Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor.

225. Efficacy of noncontact mapping in detecting epicardial activation.

226. Optimizing cardiac resuscitation outcomes using wavelet analysis.

227. [Application of telepathology to diagnosis in an interhospital network: the experience of a Parisian military hospital group].

228. Electrogram fractionation in murine HL-1 atrial monolayer model.

229. Des-A-ring benzothiadiazines: inhibitors of HCV genotype 1 NS5B RNA-dependent RNA polymerase.

230. Modification of the Stöber process by a polyazamacrocycle leading to unusual core-shell silica nanoparticles.

231. Contribution of multi-nuclear solid state NMR to the characterization of the Thalassiosira pseudonana diatom cell wall.

232. Characterization of a novel human immunodeficiency virus type 1 protease inhibitor, A-790742.

233. Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitors.

234. Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro.

235. In vitro selection and characterization of human immunodeficiency virus type 2 with decreased susceptibility to lopinavir.

237. Wave similarity of human ventricular fibrillation from bipolar electrograms.

238. Discovery of imidazolidine-2,4-dione-linked HIV protease inhibitors with activity against lopinavir-resistant mutant HIV.

239. Cardiac electrophysiological consequences of neuromuscular incapacitating device discharges.

240. Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ring.

241. Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamides.

242. Mutations conferring resistance to a hepatitis C virus (HCV) RNA-dependent RNA polymerase inhibitor alone or in combination with an HCV serine protease inhibitor in vitro.

243. Patient outcomes after discharge from a geriatric day hospital.

244. Dependence and independence of [PSI(+)] and [PIN(+)]: a two-prion system in yeast?

245. Characteristics of local electrograms with diastolic potentials: identification of different components of return pathways in ventricular tachycardia.

246. Yeast meiotic mutants proficient for the induction of ectopic recombination.

248. Endocardial mapping of ventricular tachycardia in the intact human ventricle. III. Evidence of multiuse reentry with spontaneous and induced block in portions of reentrant path complex.

249. Nurse author's guide to publishing house editors.

250. Mechanisms of spontaneous shift of surface electrocardiographic configuration during ventricular tachycardia.

Catalog

Books, media, physical & digital resources